Today, Zurich Corporate Risk has announced the introduction of Precision CancerCare™ and Second Medical Opinion+ for new policies or existing clients going through a rate retest,...
Zurich Corporate Risk has announced its latest strategic partnership with Reframe Cancer, supporting policyholders who’ve received a new cancer diagnosis.
“This campaign is about recognising the absolute need, realising the story hasn’t been told well enough so far, and harnessing the power of real-life stories,” said...
New research conducted by the Centre for Economics and Business Research (Cebr), on behalf of Zurich Insurance, has found people with long-term health conditions now account for almost...